HIGH FIBRINOGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY IN GROWTH HORMONE-DEFICIENT ADULTS

Hypopituitary patients on routine replacement therapy except growth hormone (GH) have an increased risk of death from cardiovascular diseases compared with healthy subjects. Untreated GH deficiency might explain the premature death from vascular disease. Plasminogen activator inhibitor (PAI-1) activity, fibrinogen, insulin, blood lipid, and blood pressure levels were studied in 20 GH-deficient adults (10 men, 10 women) 50+/-11 years old with routine hormone replacement therapy (except GH) and compared with 20 healthy control subjects matched for sex, age, and body mass index. GH-deficient subjects had a higher waist-to-hip circumference ratio (P<.001), serum triglycerides (P<.02), PAI-1 activity (13.2+/-10.6 versus 6.81+/-4.8 U/mL [P<.05], and fibrinogen (3.2+/-0.7 versus 2.4+/-0.6 g/L [P<.001]) and lower blood glucose (P<.05) compared with control subjects. Blood pressure, insulin, and cholesterol levels were similar. The aberrations found in this study might contribute to an increased atherothrombotic propensity and play a role in the pathogenesis of cardiovascular disease. (Arterioscler Thromb. 1994;14:434 437.)